These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22894810)

  • 1. [What to do if pills do not work for urge incontinence--still many questions and ambiguities].
    Koldewijn EL
    Ned Tijdschr Geneeskd; 2012; 156(33):A5099. PubMed ID: 22894810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuromodulation as a treatment for overactive bladder syndrome].
    Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
    Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A].
    Amend B; Castro-Diaz D; Chartier-Kastler E; De Ridder D; Everaert K; Spinelli M; van Kereebroeck P; Sievert KD
    Urologe A; 2010 Feb; 49(2):245-52. PubMed ID: 19859688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con.
    Bales GT
    J Urol; 2017 Sep; 198(3):500-501. PubMed ID: 28751016
    [No Abstract]   [Full Text] [Related]  

  • 8. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Pro.
    Kraus SR
    J Urol; 2017 Sep; 198(3):501-502. PubMed ID: 28751015
    [No Abstract]   [Full Text] [Related]  

  • 9. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin?
    Tubaro A; Puccini F; De Nunzio C
    Curr Opin Urol; 2015 Jul; 25(4):305-10. PubMed ID: 26049873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation and management of refractory neurogenic overactive bladder.
    Kurpad R; Kennelly MJ
    Curr Urol Rep; 2014 Oct; 15(10):444. PubMed ID: 25118853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradetrusor injection of botulinum toxin A and sacral neuromodulation for neurogenic detrusor overactivity.
    Joussain C; Phé V; Even A; Chartier-Kastler E; Denys P
    Eur J Phys Rehabil Med; 2017 Dec; 53(6):991-997. PubMed ID: 29072045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017.
    Malde S; Fry C; Schurch B; Marcelissen T; Averbeck M; Digesu A; Sahai A
    Neurourol Urodyn; 2018 Jun; 37(S4):S108-S116. PubMed ID: 30133790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding clinic options for overactive bladder.
    Bartley JM; Blum ES; Sirls LT; Peters KM
    Curr Urol Rep; 2013 Dec; 14(6):541-8. PubMed ID: 23812967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on the second line management of idiopathic overactive bladder].
    Chartier-Kastler E; Castro-Diaz D; De Ridder D; Everaert K; Sievert KD; Spinelli M; van Kerrebroeck P
    Prog Urol; 2009 Sep; 19(8):530-7. PubMed ID: 19699450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.
    Kantartzis K; Shepherd J
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):331-6. PubMed ID: 22922403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Idiopathic Overactive Bladder Syndrome: What Is the Optimal Strategy After Failure of Conservative Treatment?
    Marcelissen T; Cornu JN; Antunes-Lopes T; Geavlete B; Delongchamps NB; Rashid T; Rieken M; Rahnama'i MS
    Eur Urol Focus; 2018 Sep; 4(5):760-767. PubMed ID: 29807823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress urinary incontinence and overactive bladder syndrome: current options and new targets for management.
    Elser DM
    Postgrad Med; 2012 May; 124(3):42-9. PubMed ID: 22691898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.
    Chughtai B; Clemens JQ; Thomas D; Sun T; Ghomrawi H; Sedrakyan A
    J Urol; 2020 Jan; 203(1):179-184. PubMed ID: 31347949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy.
    Bhide AA; Tailor V; Fernando R; Khullar V; Digesu GA
    Int Urogynecol J; 2020 May; 31(5):865-870. PubMed ID: 31853597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.